<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39195477</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-3397</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>Marine drugs</Title><ISOAbbreviation>Mar Drugs</ISOAbbreviation></Journal><ArticleTitle>The Discovery and Characterization of a Potent DPP-IV Inhibitory Peptide from Oysters for the Treatment of Type 2 Diabetes Based on Computational and Experimental Studies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">361</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/md22080361</ELocationID><Abstract><AbstractText>The inhibition of dipeptidyl peptidase-IV (DPP-IV) is a promising approach for regulating the blood glucose levels in patients with type 2 diabetes (T2D). Oysters, rich in functional peptides, contain peptides capable of inhibiting DPP-IV activity. This study aims to identify the hypoglycemic peptides from oysters and investigate their potential anti-T2D targets and mechanisms. This research utilized virtual screening for the peptide selection, followed by in vitro DPP-IV activity assays to validate the chosen peptide. Network pharmacology was employed to identify the potential targets, GO terms, and KEGG pathways. Molecular docking and molecular dynamics simulations were used to provide virtual confirmation. The virtual screening identified LRGFGNPPT as the most promising peptide among the screened oyster peptides. The in vitro studies confirmed its inhibitory effect on DPP-IV activity. Network pharmacology revealed that LRGFGNPPT exerts an anti-T2D effect through multiple targets and signaling pathways. The key hub targets are AKT1, ACE, and REN. Additionally, the molecular docking results showed that LRGFGNPPT exhibited a strong binding affinity with targets like AKT1, ACE, and REN, which was further confirmed by the molecular dynamics simulations showcasing a stable peptide-target interaction. This study highlights the potential of LRGFGNPPT as a natural anti-T2D peptide, providing valuable insights for potential future pharmaceutical or dietary interventions in T2D management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhongqin</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-2249-7092</Identifier><AffiliationInfo><Affiliation>Shenzhen Institute of Guangdong Ocean University, Shenzhen 518120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Xiaojie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shenzhen Institute of Guangdong Ocean University, Shenzhen 518120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Wenhong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Shenzhen Institute of Guangdong Ocean University, Shenzhen 518120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Mingtang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Shenzhen Institute of Guangdong Ocean University, Shenzhen 518120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Guoping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Jialong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Longjian</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4480-4073</Identifier><AffiliationInfo><Affiliation>Shenzhen Institute of Guangdong Ocean University, Shenzhen 518120, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Aquatic Products Processing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Zhanjiang Municipal Key Laboratory of Marine Drugs and Nutrition for Brain Health, National Research and Development Branch Center for Shellfish Processing (Zhanjiang), Guangdong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaborative Innovation Center of Seafood Deep Processing, Dalian Polytechnic University, Dalian 116034, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021A1515110621</GrantID><Agency>Guangdong Basic and Applied Basic Research Foundation</Agency><Country /></Grant><Grant><GrantID>2024A1515011763</GrantID><Agency>Guangdong Basic and Applied Basic Research Foundation</Agency><Country /></Grant><Grant><GrantID>32201971</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2022E05010</GrantID><Agency>the Zhanjiang Marine Youth Talent Innovation Project</Agency><Country /></Grant><Grant><GrantID>2021E05017</GrantID><Agency>the Science and Technology Plan Project of Zhanjiang City</Agency><Country /></Grant><Grant><GrantID>060302042007 and 060302042201</GrantID><Agency>the Program for scientific research start-up funds of Guangdong Ocean University</Agency><Country /></Grant><Grant><GrantID>2021KCXTD021</GrantID><Agency>the Innovative Team Program of High Education of Guangdong Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Mar Drugs</MedlineTA><NlmUniqueID>101213729</NlmUniqueID><ISSNLinking>1660-3397</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054873">Dipeptidyl-Peptidase IV Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.14.5</RegistryNumber><NameOfSubstance UI="D018819">Dipeptidyl Peptidase 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054873" MajorTopicYN="Y">Dipeptidyl-Peptidase IV Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="Y">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018819" MajorTopicYN="Y">Dipeptidyl Peptidase 4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="Y">Peptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010125" MajorTopicYN="N">Ostreidae</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091484" MajorTopicYN="N">Network Pharmacology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DPP-IV</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword><Keyword MajorTopicYN="N">molecular dynamics simulation</Keyword><Keyword MajorTopicYN="N">network pharmacology</Keyword><Keyword MajorTopicYN="N">oyster peptides</Keyword><Keyword MajorTopicYN="N">type 2 diabetes</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39195477</ArticleId><ArticleId IdType="pmc">PMC11355449</ArticleId><ArticleId IdType="doi">10.3390/md22080361</ArticleId><ArticleId IdType="pii">md22080361</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu J.H.Y., Micha R., Mozaffarian D. Dietary fats and cardiometabolic disease: Mechanisms and effects on risk factors and outcomes. Nat. Rev. Cardiol. 2019;16:581–601. doi: 10.1038/s41569-019-0206-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0206-1</ArticleId><ArticleId IdType="pubmed">31097791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Sailani M.R., Contrepois K., Zhou Y., Ahadi S., Leopold S.R., Zhang M.J., Rao V., Avina M., Mishra T., et al. Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature. 2019;569:663–671. doi: 10.1038/s41586-019-1236-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1236-x</ArticleId><ArticleId IdType="pmc">PMC6666404</ArticleId><ArticleId IdType="pubmed">31142858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C.N., Mbanya J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109119. doi: 10.1016/j.diabres.2021.109119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2021.109119</ArticleId><ArticleId IdType="pmc">PMC11057359</ArticleId><ArticleId IdType="pubmed">34879977</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho N.H., Shaw J.E., Karuranga S., Huang Y., da Rocha Fernandes J.D., Ohlrogge A.W., Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2018.02.023</ArticleId><ArticleId IdType="pubmed">29496507</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017;40:S11–S24. doi: 10.2337/dc17-S005.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-S005</ArticleId><ArticleId IdType="pubmed">27979889</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Xu C., Zhang C., Cao W., Qin X., Gao J., Zheng H. The purification and identification of immunoregulatory peptides from oyster (Crassostrea hongkongensis) enzymatic hydrolysate. RSC Adv. 2019;9:32854–32863. doi: 10.1039/C9RA04255E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9RA04255E</ArticleId><ArticleId IdType="pmc">PMC9073163</ArticleId><ArticleId IdType="pubmed">35529727</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasov A.G., Zotchev S.B., Dirsch V.M., Supuran C.T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021;20:200–216. doi: 10.1038/s41573-020-00114-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-00114-z</ArticleId><ArticleId IdType="pmc">PMC7841765</ArticleId><ArticleId IdType="pubmed">33510482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao L., Wang X., Cao Y., Xu J., Xue C. A comprehensive review of oyster peptides: Preparation, characterisation and bioactivities. Rev. Aquacult. 2021;14:120. doi: 10.1111/raq.12588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/raq.12588</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia E.Q., Zhu S.S., He M.J., Luo F., Fu C.Z., Zou T.B. Marine peptides as potential agents for the management of type 2 diabetes mellitus-a prospect. Mar. Drugs. 2017;15:88. doi: 10.3390/md15040088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md15040088</ArticleId><ArticleId IdType="pmc">PMC5408234</ArticleId><ArticleId IdType="pubmed">28333091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dullius A., Fassina P., Giroldi M., Goettert M.I., Volken de Souza C.F. A biotechnological approach for the production of branched chain amino acid containing bioactive peptides to improve human health: A review. Food Res. Int. 2020;131:109002. doi: 10.1016/j.foodres.2020.109002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2020.109002</ArticleId><ArticleId IdType="pubmed">32247480</ArticleId></ArticleIdList></Reference><Reference><Citation>Chartrand D., Da Silva M.S., Julien P., Rudkowska I. Influence of amino acids in dairy products on glucose homeostasis: The clinical evidence. Can. J. Diabetes. 2017;41:329–337. doi: 10.1016/j.jcjd.2016.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2016.10.009</ArticleId><ArticleId IdType="pubmed">28233627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha S.A., Pintado M.E. Bioactive peptides derived from marine sources: Biological and functional properties. Trends Food Sci. Technol. 2022;119:348–370. doi: 10.1016/j.tifs.2021.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2021.08.017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins A.L. Network pharmacology. Nat. Biotechnol. 2007;25:1110–1111. doi: 10.1038/nbt1007-1110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1007-1110</ArticleId><ArticleId IdType="pubmed">17921993</ArticleId></ArticleIdList></Reference><Reference><Citation>Boezio B., Audouze K., Ducrot P., Taboureau O. Network-based approaches in pharmacology. Mol. Inform. 2017;36:1700048. doi: 10.1002/minf.201700048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.201700048</ArticleId><ArticleId IdType="pubmed">28692140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye H., Wei J., Tang K., Feuers R., Hong H. Drug repositioning through network pharmacology. Curr. Top. Med. Chem. 2016;16:3646–3656. doi: 10.2174/1568026616666160530181328.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026616666160530181328</ArticleId><ArticleId IdType="pubmed">27334200</ArticleId></ArticleIdList></Reference><Reference><Citation>Azam S.S., Abbasi S.W. Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. Theor. Biol. Med. Model. 2013;10:63. doi: 10.1186/1742-4682-10-63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4682-10-63</ArticleId><ArticleId IdType="pmc">PMC3819668</ArticleId><ArticleId IdType="pubmed">24156411</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantsar T., Poso A. Binding affinity via docking: Fact and fiction. Molecules. 2018;23:1899. doi: 10.3390/molecules23081899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23081899</ArticleId><ArticleId IdType="pmc">PMC6222344</ArticleId><ArticleId IdType="pubmed">30061498</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai K.M., Le D.P., Tran N.V., Nguyen T.T., Tran T.D., Le M.T. Computational assay of Zanamivir binding affinity with original and mutant influenza neuraminidase 9 using molecular docking. J. Theor. Biol. 2015;385:31–39. doi: 10.1016/j.jtbi.2015.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtbi.2015.08.019</ArticleId><ArticleId IdType="pubmed">26341387</ArticleId></ArticleIdList></Reference><Reference><Citation>Das P., Sercu T., Wadhawan K., Padhi I., Gehrmann S., Cipcigan F., Chenthamarakshan V., Strobelt H., Dos Santos C., Chen P.Y., et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat. Biomed. Eng. 2021;5:613–623. doi: 10.1038/s41551-021-00689-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-021-00689-x</ArticleId><ArticleId IdType="pubmed">33707779</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohlke H., Hendlich M., Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J. Mol. Biol. 2000;295:337–356. doi: 10.1006/jmbi.1999.3371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3371</ArticleId><ArticleId IdType="pubmed">10623530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevener K.E., Zhao W., Ball D.M., Babaoglu K., Qi J., White S.W., Lee R.E. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J. Chem. Inf. Model. 2009;49:444–460. doi: 10.1021/ci800293n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci800293n</ArticleId><ArticleId IdType="pmc">PMC2788795</ArticleId><ArticleId IdType="pubmed">19434845</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti A.L., Cavaliere C., Foglia P., Piovesana S., Samperi R., Zenezini Chiozzi R., Laganà A. Development of an analytical strategy for the identification of potential bioactive peptides generated by in vitro tryptic digestion of fish muscle proteins. Anal. Bioanal. Chem. 2015;407:845–854. doi: 10.1007/s00216-014-8094-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-014-8094-z</ArticleId><ArticleId IdType="pubmed">25168116</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Fan Y., Liu J., Meng Z., Huang A., Xu F., Wang X. Identification, characterization and in vitro activity of hypoglycemic peptides in whey hydrolysates from rubing cheese by-product. Food Res. Int. 2023;164:112382. doi: 10.1016/j.foodres.2022.112382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2022.112382</ArticleId><ArticleId IdType="pubmed">36737967</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Gao L., Zhang X., Wang P., Liu Y., Feng J., Zhang C., Zhao C., Zhang S. “PP-type” self-assembling peptides with superior rheological properties. Nanoscale Adv. 2021;3:6056–6062. doi: 10.1039/D1NA00534K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1NA00534K</ArticleId><ArticleId IdType="pmc">PMC9417066</ArticleId><ArticleId IdType="pubmed">36133953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin G., Wang X., Yi W., Zhang C., Xu G., Zhu X., Cai Z., Liu Y., Diao Y., Lin M.C., et al. A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma. J. Transl. Med. 2015;13:166. doi: 10.1186/s12967-015-0524-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-015-0524-y</ArticleId><ArticleId IdType="pmc">PMC4455914</ArticleId><ArticleId IdType="pubmed">25990580</ArticleId></ArticleIdList></Reference><Reference><Citation>Syam Y.M., El-Karim S.S.A., Nasr T., Elseginy S.A., Anwar M.M., Kamel M.M., Ali H.F. Design, Synthesis and Biological Evaluation of Spiro Cyclohexane-1,2- Quinazoline Derivatives as Potent Dipeptidyl Peptidase IV Inhibitors. Mini Rev. Med. Chem. 2019;19:250–269. doi: 10.2174/1389557517666170828121018.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389557517666170828121018</ArticleId><ArticleId IdType="pubmed">28847268</ArticleId></ArticleIdList></Reference><Reference><Citation>Majid A., Lakshmikanth M., Lokanath N.K., Poornima Priyadarshini C.G. Generation, characterization and molecular binding mechanism of novel dipeptidyl peptidase-4 inhibitory peptides from sorghum bicolor seed protein. Food Chem. 2022;369:130888. doi: 10.1016/j.foodchem.2021.130888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2021.130888</ArticleId><ArticleId IdType="pubmed">34474286</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen R., Chen X., Zeng Z., Ma H., Chen S. Dipeptidyl Peptidase IV-Inhibitory Peptides Derived from Silver Carp (Hypophthalmichthys molitrix Val.) Proteins. J. Agric. Food Chem. 2016;64:831–839. doi: 10.1021/acs.jafc.5b05429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.5b05429</ArticleId><ArticleId IdType="pubmed">26758401</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang R., Cheng C., Zhang Y., Ma Y., Lu W. Identification of two novel dipeptidyl peptidase-IV inhibitory peptides from sheep whey protein and inhibition mechanism revealed by molecular docking. Food Biosci. 2022;48:101733. doi: 10.1016/j.fbio.2022.101733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fbio.2022.101733</ArticleId></ArticleIdList></Reference><Reference><Citation>Daina A., Michielin O., Zoete V. SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357–W364. doi: 10.1093/nar/gkz382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz382</ArticleId><ArticleId IdType="pmc">PMC6602486</ArticleId><ArticleId IdType="pubmed">31106366</ArticleId></ArticleIdList></Reference><Reference><Citation>Piñero J., Ramírez-Anguita J.M., Saüch-Pitarch J., Ronzano F., Centeno E., Sanz F., Furlong L.I. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48:D845–D855. doi: 10.1093/nar/gkz1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1021</ArticleId><ArticleId IdType="pmc">PMC7145631</ArticleId><ArticleId IdType="pubmed">31680165</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelzer G., Rosen N., Plaschkes I., Zimmerman S., Twik M., Fishilevich S., Stein T.I., Nudel R., Lieder I., Mazor Y., et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinform. 2016;54:1.30.31–31.30.33. doi: 10.1002/cpbi.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.5</ArticleId><ArticleId IdType="pubmed">27322403</ArticleId></ArticleIdList></Reference><Reference><Citation>Whirl-Carrillo M., Huddart R., Gong L., Sangkuhl K., Thorn C.F., Whaley R., Klein T.E. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 2021;110:563–572. doi: 10.1002/cpt.2350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2350</ArticleId><ArticleId IdType="pmc">PMC8457105</ArticleId><ArticleId IdType="pubmed">34216021</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes J.M., Coughlan M.T., Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446–1454. doi: 10.2337/db08-0057.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db08-0057</ArticleId><ArticleId IdType="pubmed">18511445</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K. Obesity and diabetic kidney disease: Role of oxidant stress and redox balance. Antioxid. Redox Signal. 2016;25:208–216. doi: 10.1089/ars.2016.6696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2016.6696</ArticleId><ArticleId IdType="pmc">PMC4964755</ArticleId><ArticleId IdType="pubmed">26983586</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajja R.K., Prasad S., Cucullo L. Impact of altered glycaemia on blood-brain barrier endothelium: An in vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS. 2014;11:8. doi: 10.1186/2045-8118-11-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-11-8</ArticleId><ArticleId IdType="pmc">PMC3985548</ArticleId><ArticleId IdType="pubmed">24708805</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C.X., Zhu H.H., Zhu Y.M. Diabetes and cancer: Associations, mechanisms, and implications for medical practice. World J. Diabetes. 2014;5:372–380. doi: 10.4239/wjd.v5.i3.372.</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v5.i3.372</ArticleId><ArticleId IdType="pmc">PMC4058741</ArticleId><ArticleId IdType="pubmed">24936258</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticcio L., Maiorino M.I., Bellastella G., Giugliano D., Esposito K. Insights into the relationships between diabetes, prediabetes, and cancer. Endocrine. 2017;56:231–239. doi: 10.1007/s12020-016-1216-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-016-1216-y</ArticleId><ArticleId IdType="pubmed">28040833</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao H., Guo T., Yang M., Qi J., Huang C., Hong Y., Gu J., Pang X., Liu W.J., Peng R., et al. Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses. Cell Discov. 2019;5:21. doi: 10.1038/s41421-019-0086-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-019-0086-x</ArticleId><ArticleId IdType="pmc">PMC6465249</ArticleId><ArticleId IdType="pubmed">30993000</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla P., Pandey P., Prasad B., Robinson T., Purohit R., D’Cruz L.G., Tambuwala M.M., Mutreja A., Harkin J., Rai T.S., et al. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage. Brief. Bioinform. 2022;23:bbab496. doi: 10.1093/bib/bbab496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab496</ArticleId><ArticleId IdType="pmc">PMC8769887</ArticleId><ArticleId IdType="pubmed">34962259</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L., Shi S., Yi J., Wang N., He Y., Wu Z., Peng J., Deng Y., Wang W., Wu C., et al. ADMETlab 3.0: An updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024;52:W422–W431. doi: 10.1093/nar/gkae236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkae236</ArticleId><ArticleId IdType="pmc">PMC11223840</ArticleId><ArticleId IdType="pubmed">38572755</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasteiger E., Hoogland C., Gattiker A., Duvaud S.e., Wilkins M.R., Appel R.D., Bairoch A. Protein Identification and Analysis Tools on the ExPASy Server. In: Walker J.M., editor. The Proteomics Protocols Handbook. Humana Press; Totowa, NJ, USA: 2005. pp. 571–607.</Citation></Reference><Reference><Citation>Sasaoka Y., Takagi T., Michiba S., Yamamoto Y., Kumagai Y., Kishimura H. Study on the mechanism of the blood-glucose-lowering effect of collagen peptides from sturgeon by-products. Mar. Drugs. 2021;19:584. doi: 10.3390/md19100584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md19100584</ArticleId><ArticleId IdType="pmc">PMC8541525</ArticleId><ArticleId IdType="pubmed">34677483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix I.M.E., Li-Chan E.C.Y. Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach. J. Funct. Foods. 2012;4:403–422. doi: 10.1016/j.jff.2012.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2012.01.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Liu X., Li Y., You H., Yu Z., Wang L., Liu X., Ding L. Identification and characterization of dipeptidyl peptidase-IV inhibitory peptides from oat proteins. Foods. 2022;11:1406. doi: 10.3390/foods11101406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods11101406</ArticleId><ArticleId IdType="pmc">PMC9141920</ArticleId><ArticleId IdType="pubmed">35626976</ArticleId></ArticleIdList></Reference><Reference><Citation>Elam E., Feng J., Lv Y.-M., Ni Z.-J., Sun P., Thakur K., Zhang J.-G., Ma Y.-L., Wei Z.-J. Recent advances on bioactive food derived anti-diabetic hydrolysates and peptides from natural resources. J. Funct. Foods. 2021;86:104674. doi: 10.1016/j.jff.2021.104674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2021.104674</ArticleId></ArticleIdList></Reference><Reference><Citation>Obaroakpo J.U., Liu L., Zhang S., Lu J., Liu L., Pang X., Lv J. In vitro modulation of glucagon-like peptide release by DPP-IV inhibitory polyphenol-polysaccharide conjugates of sprouted quinoa yoghurt. Food Chem. 2020;324:126857. doi: 10.1016/j.foodchem.2020.126857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2020.126857</ArticleId><ArticleId IdType="pubmed">32344342</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestri E., Pavlicevic M., Montorsi M., Marmiroli N. Meta-analysis for correlating structure of bioactive peptides in foods of animal origin with regard to effect and stability. Compr. Rev. Food Sci. Food Saf. 2019;18:3–30. doi: 10.1111/1541-4337.12402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1541-4337.12402</ArticleId><ArticleId IdType="pubmed">33337011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacroix I.M.E., Chen X.M., Kitts D.D., Li-Chan E.C.Y. Investigation into the bioavailability of milk protein-derived peptides with dipeptidyl-peptidase IV inhibitory activity using Caco-2 cell monolayers. Food Funct. 2017;8:701–709. doi: 10.1039/C6FO01411A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6FO01411A</ArticleId><ArticleId IdType="pubmed">28098291</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Montoya M., Hernández-Ledesma B., Mora-Escobedo R., Martínez-Villaluenga C. Bioactive peptides from germinated soybean with anti-diabetic potential by inhibition of dipeptidyl peptidase-iv, α-amylase, and α-glucosidase enzymes. Int. J. Mol. Sci. 2018;19:2883. doi: 10.3390/ijms19102883.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19102883</ArticleId><ArticleId IdType="pmc">PMC6213256</ArticleId><ArticleId IdType="pubmed">30249015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dvoretskaya Y., Glanz V., Gryaznova M., Syromyatnikov M., Popov V. Mitochondrial antioxidant SkQ1 has a beneficial effect in experimental diabetes as based on the analysis of expression of microRNAs and mRNAs for the oxidative metabolism regulators. Antioxidants. 2021;10:1749. doi: 10.3390/antiox10111749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10111749</ArticleId><ArticleId IdType="pmc">PMC8615282</ArticleId><ArticleId IdType="pubmed">34829620</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Stepicheva N.A., Ghosh S., Shang P., Chowdhury O., Daley R.A., Yazdankhah M., Gupta U., Hose S.L., Valapala M., et al. Reducing Akt2 in retinal pigment epithelial cells causes a compensatory increase in Akt1 and attenuates diabetic retinopathy. Nat. Commun. 2022;13:6045. doi: 10.1038/s41467-022-33773-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33773-0</ArticleId><ArticleId IdType="pmc">PMC9561713</ArticleId><ArticleId IdType="pubmed">36229454</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Li W., Guo Q., Xu L., Santhanam R.K., Gao X., Chen Y., Wang C., Panichayupakaranant P., Chen H. Anthocyanins from dietary black soybean potentiate glucose uptake in L6 rat skeletal muscle cells via up-regulating phosphorylated Akt and GLUT4. J. Funct. Foods. 2019;52:663–669. doi: 10.1016/j.jff.2018.11.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2018.11.049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F., Zhang G., Yang X., Wang M., Wang R., Wan M., Wang J., Wu B., Yan T., Jia Y. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway. J. Ethnopharmacol. 2023;303:115933. doi: 10.1016/j.jep.2022.115933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2022.115933</ArticleId><ArticleId IdType="pubmed">36403742</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson S., Jung F.F., Ingelfinger J.R. Renal renin-angiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations. Am. J. Physiol. 1993;265:F477–F486. doi: 10.1152/ajprenal.1993.265.4.F477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.1993.265.4.F477</ArticleId><ArticleId IdType="pubmed">8238377</ArticleId></ArticleIdList></Reference><Reference><Citation>Saumya M., Subin E.K., Suchithra T.V. Network analysis of MPO and other relevant proteins involved in diabetic foot ulcer and other diabetic complications. Interdiscip. Sci. 2019;11:180–190. doi: 10.1007/s12539-017-0258-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12539-017-0258-z</ArticleId><ArticleId IdType="pubmed">28905321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi T., Kawaguchi M., Sugimoto K., Uekita H., Sakamoto N., Yokoyama K., Maruyama Y., Takeishi Y. Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes. J. Atheroscler. Thromb. 2010;17:578–589. doi: 10.5551/jat.3590.</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.3590</ArticleId><ArticleId IdType="pubmed">20215707</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuissa H., Jones P.G., Marso S.P., O’Keefe J.H., Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: A meta-analysis of randomized clinical trials. J. Am. Coll. Cardiol. 2005;46:821–826. doi: 10.1016/j.jacc.2005.05.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.05.051</ArticleId><ArticleId IdType="pubmed">16139131</ArticleId></ArticleIdList></Reference><Reference><Citation>Niechciał E., Acerini C.L., Chiesa S.T., Stevens T., Dalton R.N., Daneman D., Deanfield J.E., Jones T.W., Mahmud F.H., Marshall S.M., et al. Medication adherence during adjunct therapy with statins and ACE inhibitors in adolescents with type 1 diabetes. Diabetes Care. 2020;43:1070–1076. doi: 10.2337/dc19-0884.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc19-0884</ArticleId><ArticleId IdType="pmc">PMC7282885</ArticleId><ArticleId IdType="pubmed">32108022</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph J.J., Echouffo Tcheugui J.B., Effoe V.S., Hsueh W.A., Allison M.A., Golden S.H. Renin-angiotensin-aldosterone system, glucose metabolism and incident type 2 diabetes mellitus: MESA. J. Am. Heart Assoc. 2018;7:e009890. doi: 10.1161/JAHA.118.009890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.009890</ArticleId><ArticleId IdType="pmc">PMC6201432</ArticleId><ArticleId IdType="pubmed">30371168</ArticleId></ArticleIdList></Reference><Reference><Citation>Osonoi T., Gouda M., Kubo M., Arakawa K., Hashimoto T., Abe M. Effect of canagliflozin on urinary albumin excretion in japanese patients with type 2 diabetes mellitus and microalbuminuria: A pilot study. Diabetes Technol. Ther. 2018;20:681–688. doi: 10.1089/dia.2018.0169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dia.2018.0169</ArticleId><ArticleId IdType="pmc">PMC6161332</ArticleId><ArticleId IdType="pubmed">30096243</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Awadhi F.H., Luesch H. Targeting eukaryotic proteases for natural products-based drug development. Nat. Prod. Rep. 2020;37:827–860. doi: 10.1039/C9NP00060G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9NP00060G</ArticleId><ArticleId IdType="pmc">PMC7406119</ArticleId><ArticleId IdType="pubmed">32519686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchens T., Piston D.W. EphA4 receptor forward signaling inhibits glucagon secretion from α-cells. Diabetes. 2015;64:3839–3851. doi: 10.2337/db15-0488.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db15-0488</ArticleId><ArticleId IdType="pmc">PMC4613968</ArticleId><ArticleId IdType="pubmed">26251403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismaeil A., Babiker F., Al-Sabah S. Discrepancy between the actions of glucagon-like peptide-1 receptor ligands in the protection of the heart against ischemia reperfusion injury. Pharmaceuticals. 2022;15:720. doi: 10.3390/ph15060720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15060720</ArticleId><ArticleId IdType="pmc">PMC9228343</ArticleId><ArticleId IdType="pubmed">35745639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn B., Wan S., Jaiswal N., Vega R.B., Ayer D.E., Titchenell P.M., Han X., Won K.J., Kelly D.P. MondoA drives muscle lipid accumulation and insulin resistance. JCI Insight. 2019;5:e129119. doi: 10.1172/jci.insight.129119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.129119</ArticleId><ArticleId IdType="pmc">PMC6693825</ArticleId><ArticleId IdType="pubmed">31287806</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker R., Yiannikouris F., Thatcher S., Cassis L. ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice. Am. J. Physiol. Endocrinol. Metab. 2015;309:E621–E631. doi: 10.1152/ajpendo.00054.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00054.2015</ArticleId><ArticleId IdType="pmc">PMC4593774</ArticleId><ArticleId IdType="pubmed">26389599</ArticleId></ArticleIdList></Reference><Reference><Citation>Asghar O., Al-Sunni A., Khavandi K., Khavandi A., Withers S., Greenstein A., Heagerty A.M., Malik R.A. Diabetic cardiomyopathy. Clin. Sci. 2009;116:741–760. doi: 10.1042/CS20080500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20080500</ArticleId><ArticleId IdType="pmc">PMC2782307</ArticleId><ArticleId IdType="pubmed">19364331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., He Y., Yu D., Jin L., Gong X., Zhang B. Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice. Food Chem. Toxicol. 2020;135:110965. doi: 10.1016/j.fct.2019.110965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2019.110965</ArticleId><ArticleId IdType="pubmed">31743741</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Liu G., Guo J., Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 2018;14:1483–1496. doi: 10.7150/ijbs.27173.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.27173</ArticleId><ArticleId IdType="pmc">PMC6158718</ArticleId><ArticleId IdType="pubmed">30263000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Xie Y.Z., Peng C.W., Yao K.N., Lin X.Y., Zhan S.F., Zhuang H.F., Huang H.T., Liu X.H., Huang X.F., et al. Modeling Kaempferol as a potential pharmacological agent for COVID-19/PF co-occurrence based on bioinformatics and system pharmacological tools. Front. Pharmacol. 2022;13:865097. doi: 10.3389/fphar.2022.865097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.865097</ArticleId><ArticleId IdType="pmc">PMC9214245</ArticleId><ArticleId IdType="pubmed">35754492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Chen Z.Q., Cao W.H., Gao J.L., Zheng H.N., Lin H.S., Zhang C.H., Qin X.M. Structural characteristics of antioxidant and hypoglycemic peptides from oyster (Crassostrea hongkongensis) and their simulated digestion characteristics in vitro. Food Ferment. Ind. 2022;48:196–203. doi: 10.13995/j.cnki.11-1802/ts.032705.</Citation><ArticleIdList><ArticleId IdType="doi">10.13995/j.cnki.11-1802/ts.032705</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: An open chemical toolbox. J. Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785–2791. doi: 10.1002/jcc.21256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21256</ArticleId><ArticleId IdType="pmc">PMC2760638</ArticleId><ArticleId IdType="pubmed">19399780</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt J., Santos-Martins D., Tillack A.F., Forli S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 2021;61:3891–3898. doi: 10.1021/acs.jcim.1c00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c00203</ArticleId><ArticleId IdType="pmc">PMC10683950</ArticleId><ArticleId IdType="pubmed">34278794</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455–461. doi: 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Kirsch R., Koutrouli M., Nastou K., Mehryary F., Hachilif R., Gable A.L., Fang T., Doncheva N.T., Pyysalo S., et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–D646. doi: 10.1093/nar/gkac1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1000</ArticleId><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark A., Teemu J.M., Roland S., Szilárd P., Jeremy C.S., Berk H., Erik L. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1–2:19–22. doi: 10.1016/j.softx.2015.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.softx.2015.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99sb. J. Chem. Theory Comput. 2015;11:3696–3713. doi: 10.1021/acs.jctc.5b00255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00255</ArticleId><ArticleId IdType="pmc">PMC4821407</ArticleId><ArticleId IdType="pubmed">26574453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>